Results 81 to 90 of about 506,611 (220)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?

Vaccines, 2019
Since the introduction of the 13-valent pneumococcal conjugate vaccine, a number of studies have demonstrated the limited efficacy of the pneumococcal serotype 3 component of this vaccine. Evidence from seven countries (Denmark, France, Greece, Portugal,
Ezra Linley, Abigail Bell, Jenna F. Gritzfeld, Ray Borrow   +3 more
doaj   +1 more source

Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. [PDF]

, 2008
BACKGROUND: The study describes the molecular epidemiology of Streptococcus pneumoniae causing invasive disease in Gambian children METHODS: One hundred and thirty-two S. pneumoniae isolates were recovered from children aged 2-29 months during the course
Pfluger Valentin, Greenwood, Brian M, O'Callaghan John, O'Callaghan, John, Oluwalana Claire, Okoko Brown, Pfluger, Valentin, Biney, Ekow, Oluwalana, Claire, Cutts Felicity, Cutts, Felicity, Biney Ekow, Pluschke Gerd, Awine, Tim, Okoko, Brown, Awine Tim, Vaughan Adeola, Antonio Martin, Enwere Godwin, Adegbola Richard A, Zaman, Syed Ma, Dada-Adegbola Hannah, Adegbola, Richard A, Enwere, Godwin, Vaughan, Adeola, Dada-Adegbola, Hannah, Zaman Syed MA, Greenwood Brian M, Antonio, Martin, Pluschke, Gerd, Martin Antonio, Gerd Pluschke, Ekow Biney, Syed MA Zaman, Valentin Pfluger, Adeola Vaughan, Brown Okoko, John O'Callaghan, Richard A Adegbola, Tim Awine, Godwin Enwere, Felicity Cutts, Hannah Dada-Adegbola, Brian M Greenwood, Claire Oluwalana   +44 more
core   +2 more sources

Will Extended‐Valency Pneumococcal Conjugate Vaccines Offer Enhanced Coverage Against Invasive Pneumococcal Disease for At‐Risk Children?

Acta Paediatrica, Volume 115, Issue 11, Page 2640-2643, November 2026.
Robert Cohen, Corinne Levy, Naim Ouldali, Stéphane Béchet, Aude Estivaux, André Birgy, Isabelle Hau, IPD Study Group, Emmanuelle Varon   +8 more
wiley   +1 more source

Past and Present Vaccinations in Sweden

Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Sven Arne Silfverdal
wiley   +1 more source

Pneumococcal conjugate vaccine--a health priority.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2008
Pneumonia is a major cause of childhood mortality and morbidity. Streptococcus pneumoniae is the most important bacterial pathogen causing pneumonia in children. The HIV epidemic has increased the burden and severity of childhood pneumococcal pneumonia and invasive disease fortyfold.
Zar, Heather J, Madhi, Shabir A
openaire   +3 more sources

Pneumococcal conjugate vaccine use in adults

Expert Review of Vaccines, 2015
Streptococcus pneumoniae is a leading cause of illness and death in adults. A polysaccharide vaccine has been available for over 30 years, but despite significant use, the public health impact of this vaccine has been limited. The 13-valent pneumococcal conjugate vaccine (PCV13) has been licensed by the US Food and Drug Administration and other ...
Raul E. Isturiz, Beate Schmoele-Thoma, Daniel A. Scott, Luis Jodar, Chris Webber, Heather L. Sings, Peter Paradiso   +6 more
openaire   +2 more sources

Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic Disease

Emerging Infectious Diseases, 1999
To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age.
Anthony E. Fiore, Orin S. Levine, John A. Elliott, Richard R. Facklam, Jay C. Butler   +4 more
doaj   +1 more source

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children

Journal of Immunology Research, 2015
Applications of the heptavalent pneumococcal conjugate vaccine (PCV7) in the pediatric immunization schedule have dramatically reduced the incidence of pneumococcal diseases in both vaccinated children and unvaccinated individuals of all ages.
Susanna Esposito, Nicola Principi
doaj   +1 more source

Pneumococcal conjugate vaccine : what you need to know [PDF]

Vaccine Information Statement (Interim) Pneumococcal Conjugate Vaccinepcv.pdf1. Why get vaccinated? -- 2. Pneumococcal conjugate vaccine -- 3. Talk with your health care provider -- 4. Risks of a vaccine reaction -- 5. What if there is a serious problem?

core   +2 more sources

Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy

Human Vaccines & Immunotherapeutics, 2017
Pneumococcal diseases are associated with a significant clinical and economic burden. The 7-valent pneumococcal conjugate vaccine (PCV-7) has been used for the immunization of newborns against invasive pneumococcal diseases (IPD) in Italy while now, the ...
Paolo Castiglia, Lorenzo Pradelli, Stefano Castagna, Veronica Freguglia, Giorgio Palù, Susanna Esposito   +5 more
doaj   +1 more source